Alnylam Pharmaceuticals (ALNY) PT Raised to $280 at JPMorgan

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Alnylam Pharmaceuticals (ALNY) PT Raised to $280 at JPMorgan

RBC Capital Reiterates Outperform Rating on Alnylam Pharmaceuticals (ALNY)

August 26, 2024 6:27 AM EDT

RBC Capital analyst Luca Issi reiterated an Outperform rating and $300.00 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY).

The analyst comments "Following positive top-line data that unlocked $15b in market cap and with the stock +70% since, ALNY will share full HELIOS-B data on Friday at European Society Of Cardiology in London. Multiple outcomes are possible (in the context of an overwhelmingly positive trial that reduced mortality by 36%) but after... More